Last quarter (Q0 0), Neovacs SA's total revenue was $1.45M, a decrease of ― from the same quarter last year. In Q0, Neovacs SA's net income was $-13.84M. See Neovacs SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 3.14M	$ 3.81M	$ 2.55M	$ 1.96M	$ 75.62K	$ 107.72K
Cost of Revenue	$ 688.97K	$ 773.83K	$ 555.70K	$ 446.24K	$ 262.69K	$ 326.64K
Gross Profit	$ 2.45M	$ 3.03M	$ 1.99M	$ 1.51M	$ -187.07K	$ -218.92K
Operating Expense	$ 28.86M	$ 41.48M	$ 31.38M	$ 36.39M	$ 7.99M	$ 12.86M
Operating Income	$ -26.41M	$ -38.45M	$ -29.38M	$ -34.88M	$ -8.17M	$ -13.08M
Net Non Operating Interest Income Expense	$ 8.98M	$ -1.05M	$ 9.15M	$ -358.08K	$ -289.15K	$ -689.78K
Other Income Expense	$ 8.59M	$ 1.63M	$ 13.73M	$ 5.31M	$ ―	$ ―
Pretax Income	$ -28.09M	$ -41.18M	$ -24.80M	$ -29.22M	$ -9.30M	$ -13.56M
Tax Provision	$ 127.56K	$ 24.74K	$ 86.69K	$ -524.06K	$ -1.75M	$ -2.77M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -28.22M	$ -41.20M	$ -24.89M	$ -28.70M	$ -7.55M	$ -10.78M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 17.95M	$ 42.25M	$ -31.93M	$ -36.84M	$ 8.25M	$ 13.19M
Net Income From Continuing And Discontinued Operation	$ -28.22M	$ -41.20M	$ -24.89M	$ -28.70M	$ -7.55M	$ -10.78M
Normalized Income	$ -16.20M	$ -30.27M	$ ―	$ -29.74M	$ -6.87M	$ -10.95M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ 106.89K	$ 153.86K
EBIT	$ -36.67M	$ -39.66M	$ -33.95M	$ -28.86M	$ -9.20M	$ -13.40M
EBITDA	$ -19.11M	$ -35.04M	$ ―	$ ―	$ -9.14M	$ -13.03M

Currency in USD

Neovacs SA Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing